284
Views
8
CrossRef citations to date
0
Altmetric
Review

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer

, , , &
Pages 199-211 | Published online: 30 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mohamed Fawzi Kabil, Osama A. Badary, Frank Bier, Shaker A. Mousa & Ibrahim M. El-Sherbiny. (2023) A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials. Journal of Liposome Research 0:0, pages 1-43.
Read now
Bantari W K Wardhani, Melva Louisa, Yukihide Watanabe, Rianto Setiabudy & Mitsuyasu Kato. (2021) TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration. Breast Cancer: Targets and Therapy 13, pages 529-538.
Read now

Articles from other publishers (6)

Laura A. Huppert, Ozge Gumusay, Dame Idossa & Hope S. Rugo. (2023) Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer. CA: A Cancer Journal for Clinicians.
Crossref
Amira Mansour, Mohamed Y. Mahmoud, Alaa F. Bakr, Monira G. Ghoniem, Fatima A. Adam & Ibrahim M. El-Sherbiny. (2023) Fortified anti-proliferative activity of niclosamide for breast cancer treatment: In-vitro and in-vivo assessment. Life Sciences 316, pages 121379.
Crossref
Christian Manginstar, Mendy Hatibie Oley, Maximillian Christian Oley, Marselus Merung, Fima Lanra Fredrik G. Langi, Billy Johnson Kepel, Lie Venny Rusli, Andi Asadul Islam & Muhammad Faruk. (2023) Correlation analysis of HIF-1α and Ca15-3 in response to neoadjuvant chemotherapy in locally advanced breast cancer: A cohort study in Indonesia. Breast Disease 41:1, pages 481-487.
Crossref
David Aguiar, Laura Ros, Daniel Pérez, Laura Croissier, Marta Mori, María Hernández, Ana Milena Vargas, Saray Galván, Carla Antonilli & Salvador Saura. (2022) Impact of body mass index on pathological complete response and survival of breast cancer patients receiving neoadjuvant chemotherapy. Breast Disease 41:1, pages 351-361.
Crossref
Carmen Herrero Vicent, Xavier Tudela, Paula Moreno Ruiz, Víctor Pedralva, Ana Jiménez Pastor, Daniel Ahicart, Silvia Rubio Novella, Isabel Meneu, Ángela Montes Albuixech, Miguel Ángel Santamaria, María Fonfria, Almudena Fuster-Matanzo, Santiago Olmos Antón & Eduardo Martínez de Dueñas. (2022) Machine Learning Models and Multiparametric Magnetic Resonance Imaging for the Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancers 14:14, pages 3508.
Crossref
Majid Omari, Btissame Zarrouq, Lamiae Amaadour, Zineb Benbrahim, Achraf El Asri, Nawfel Mellas, Karima El Rhazi, Mohammed El Amine Ragala & Karima Halim. (2022) Psychological Distress, Coping Strategies, and Quality of Life in Breast Cancer Patients Under Neoadjuvant Therapy: Protocol of a Systematic Review. Cancer Control 29, pages 107327482210747.
Crossref